Buss W C, Stalter K, Stepanek J, Piatt M K
J Steroid Biochem. 1987 Aug;28(2):129-38. doi: 10.1016/0022-4731(87)90368-2.
In experiments designed to study the mechanism of glucocorticoid hormone induced reductions in rat thymic transcription, adrenalectomized rats were injected with hydrocortisone (50 mg/kg) or control vehicle 12 h prior to sacrifice. Thymic nuclei were used to prepare soluble nuclear extracts containing RNA polymerase II. Nuclear extract RNA polymerases II were then partially purified (600-fold) on DEAE-Sephadex columns and characterized. The responses of partially purified thymic RNA polymerases II from rats treated in vivo with hydrocortisone or vehicle were similar to: pH, temperature, ionic strength, trypsin proteolysis, and inhibition by alpha-amanitin; however, RNA polymerase II from hydrocortisone treated animals was consistently reduced in activity compared to control RNA polymerase II. Determination of the apparent specific activities of peak RNA polymerase II fractions from DEAE-Sephadex columns suggested that the specific activity of RNA polymerase II from hydrocortisone treated animals was reduced compared to RNA polymerase II activity from control animals. The fact that both nuclear extract and partially purified RNA polymerases II from hydrocortisone treated rats were reduced in activity when assayed in reconstituted transcriptive systems suggests a denatured, defective or modified RNA polymerase II molecule acting as a transcription inhibitor. Thermally denatured nucleoplasmic RNA polymerase II fractions were shown to interfere with transcription by native nucleoplasmic RNA polymerase II in vitro, but did not appear to inhibit transcription to he degree observed in vitro following in vivo hydrocortisone administration.
在旨在研究糖皮质激素诱导大鼠胸腺转录减少机制的实验中,在处死前12小时给肾上腺切除的大鼠注射氢化可的松(50mg/kg)或对照赋形剂。用胸腺细胞核制备含有RNA聚合酶II的可溶性核提取物。然后将核提取物RNA聚合酶II在DEAE-葡聚糖柱上进行部分纯化(600倍)并进行特性鉴定。来自体内用氢化可的松或赋形剂处理的大鼠的部分纯化胸腺RNA聚合酶II的反应在以下方面相似:pH、温度、离子强度、胰蛋白酶水解以及α-鹅膏蕈碱抑制;然而,与对照RNA聚合酶II相比,来自氢化可的松处理动物的RNA聚合酶II活性持续降低。对来自DEAE-葡聚糖柱的RNA聚合酶II峰组分的表观比活性的测定表明,与对照动物的RNA聚合酶II活性相比,来自氢化可的松处理动物的RNA聚合酶II的比活性降低。当在重组转录系统中进行测定时,来自氢化可的松处理大鼠的核提取物和部分纯化的RNA聚合酶II的活性均降低,这一事实表明存在一种变性、有缺陷或修饰的RNA聚合酶II分子作为转录抑制剂。热变性的核质RNA聚合酶II组分在体外显示会干扰天然核质RNA聚合酶II的转录,但似乎不会像体内给予氢化可的松后在体外观察到的那样抑制转录。